Aperio Group’s Enzo Biochem, Inc. ENZ Stock Holding History

Aperio Group’s Portfolio ENZ Stock Details ENZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-828	Closed	-$3K	–	2796
2019 Q2	$3K	Buy	+828	New	+$2.92K	﹤0.01%	2900

Other funds holding ENZ

HFA

Harbert Fund Advisors Birmingham, Alabama $3.03M AUM 40.55% 1-Year Est. Return

EGA

Evermore Global Advisors Summit, New Jersey $26.3M AUM 7.42% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Aperio Group's ENZ Position: Q3 2019 in Review

Aperio Group sold out of Enzo Biochem, Inc. (ENZ) in Q3 2019, closing a stake of 828 shares — an estimated $3K sold.

Aperio Group first reported a position in ENZ in Q2 2019 and held it in 1 quarter. The position peaked at $3K in Q2 2019. 87 funds tracked by Wall St. Rank hold ENZ as of Q3 2019.

Aperio Group reported no remaining Enzo Biochem, Inc. position as of Q3 2019 after selling out during the quarter.
Aperio Group sold 828 Enzo Biochem, Inc. shares in Q3 2019, an estimated $3K.
Aperio Group first reported a position in Enzo Biochem, Inc. in Q2 2019 and held it in 1 quarter.
Aperio Group's Enzo Biochem, Inc. position peaked at $3K in Q2 2019.
87 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q3 2019.

Based on Aperio Group's 13F filing for Q3 2019, filed 6 Nov 2019.